{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T09:01:34Z","timestamp":1768899694485,"version":"3.49.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"the National Nature Foundation","award":["31701307"],"award-info":[{"award-number":["31701307"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,16]]},"abstract":"<jats:p>\n                    This study aims to investigate the increased risk of adverse pregnancy outcomes on patients who have a polycystic ovary syndrome (PCOS) with high ovarian response. The data of patients (3841 cycles) with ovarian high response who conceive in vitro fertilization\/intracytoplasmic sperm injection (IVF\/ICSI) in our hospital from January 2016 to June 2020 were picked out. According to with or without PCOS, the cycles were divided into PCOS group and non-PCOS group. After propensity score matching matching, 649 cycles in each group were analyzed. There was no significant difference in general conditions between the 2 groups (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&gt;\u2005.05), but the Anti-M\u00fcllerian hormone (8.30\u2005\u00b1\u20053.96 vs 6.36\u2005\u00b1\u20053.42;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001***) and Antral follicle count (AFC) (22.71\u2005\u00b1\u20054.56 vs 19.56\u2005\u00b1\u20055.66;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001***) of PCOS group were significantly higher than those of non-PCOS group. No significant differences were found in the thickness of endometrium on the day of human chorionic gonadotropin (hCG) day (12.28\u2005\u00b1\u20052.38 vs 12.18\u2005\u00b1\u20052.41;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.444) but progesterone (0.97\u2005\u00b1\u20050.57 vs 1.16\u2005\u00b1\u20050.69;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001***) was remarkably lower than that in non-PCOS group. Number of oocytes retrieved (23.33\u2005\u00b1\u20056.45 vs 22.57\u2005\u00b1\u20055.73;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.025*), high-quality embryo rate (60.6 vs 53.6;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001***) and high-quality blastocyst rate (15.2 vs 11.5;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001***) were significantly higher in the PCOS group than those in the non-PCOS group. The rates of freezing all embryos cycles due to high ovarian response (52.4 vs 43.1;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.001**), clinical pregnancy (84.2 vs 74.0;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.012*) and live birth (73.8 vs 61.2;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.001**) were all significantly higher in PCOS group than non-PCOS group, however, with no significant difference in the rates of preterm birth (6.3 vs 9.9;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.153), ovarian hyperstimulation syndrome (OHSS) (3.5 vs 3.7;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.179) and OHSS in clinical pregnancy (3.2 vs 3.8;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.067) between the 2 groups were found. These findings suggest that tailored treatment protocols, including individualized ovarian stimulation strategies and careful management of OHSS, may optimize reproductive outcomes in high-response PCOS patients.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000046509","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T19:01:58Z","timestamp":1768849318000},"page":"e46509","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of in vitro fertilization outcomes between patients with and without polycystic ovary syndrome"],"prefix":"10.1097","volume":"105","author":[{"given":"Xueshan","family":"Ma","sequence":"first","affiliation":[{"name":"Center of Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China"},{"name":"Department of Reproductive Genetics, Central Hospital of Tai\u2019an, Tai\u2019an, Shandong, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludan","family":"Chao","sequence":"additional","affiliation":[{"name":"Center of Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2992-3573","authenticated-orcid":false,"given":"Xianju","family":"Huang","sequence":"additional","affiliation":[{"name":"Center of Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260119","doi-asserted-by":"crossref","first-page":"e3714","DOI":"10.1210\/clinem\/dgac370","article-title":"Comparison of 3 different AMH assays with AMH levels and follicle count in women with polycystic ovary syndrome.","volume":"107","author":"Moolhuijsen","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"R2-20260119","first-page":"828","article-title":"Assisted reproductive technology clinical key indicators of quality control expert consensus.","volume":"27","author":"Linli","year":"2018","journal-title":"J Reprod Med"},{"key":"R3-20260119","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/14647273.2017.1293851","article-title":"The high responder: a review of pathophysiology and outcomes during IVF treatment.","volume":"20","author":"Mascarenhas","year":"2017","journal-title":"Hum Fertil (Camb)"},{"key":"R4-20260119","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.fertnstert.2020.03.029","article-title":"Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection.","volume":"114","author":"Witz","year":"2020","journal-title":"Fertil Steril"},{"key":"R5-20260119","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1093\/humrep\/dew268","article-title":"A short course of metformin does not reduce OHSS in a GnRH antagonist cycle for women with PCOS undergoing IVF: a randomised placebo-controlled trial.","volume":"31","author":"Jacob","year":"2016","journal-title":"Hum Reprod"},{"key":"R6-20260119","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod"},{"key":"R7-20260119","doi-asserted-by":"crossref","first-page":"575337","DOI":"10.3389\/fendo.2020.575337","article-title":"Pregnancy outcomes of women with polycystic ovary syndrome for the first in vitro fertilization treatment: a retrospective cohort study with 7678 patients.","volume":"11","author":"Liu","year":"2020","journal-title":"Front Endocrinol"},{"key":"R8-20260119","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(07)60360-2","article-title":"A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial.","volume":"369","author":"Heijnen","year":"2007","journal-title":"Lancet"},{"key":"R9-20260119","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.fertnstert.2005.07.1292","article-title":"Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.","volume":"85","author":"Papanikolaou","year":"2006","journal-title":"Fertil Steril"},{"key":"R10-20260119","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.fertnstert.2013.04.024","article-title":"Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis.","volume":"100","author":"Broer","year":"2013","journal-title":"Fertil Steril"},{"key":"R11-20260119","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.fertnstert.2016.08.048","article-title":"Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline.","volume":"106","year":"2016","journal-title":"Fertil Steril"},{"key":"R12-20260119","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0015-0282(97)00364-6","article-title":"Severe ovarian hyperstimulation syndrome: is it really preventable by prophylactic intravenous albumin?","volume":"68","author":"Ndukwe","year":"1997","journal-title":"Fertil Steril"},{"key":"R13-20260119","doi-asserted-by":"crossref","first-page":"740377","DOI":"10.3389\/fendo.2021.740377","article-title":"Association between menstrual patterns and adverse pregnancy outcomes in patients with polycystic ovary syndrome.","volume":"12","author":"Yu","year":"2021","journal-title":"Front Endocrinol"},{"key":"R14-20260119","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.fertnstert.2019.01.026","article-title":"Higher chromosomal aberration rate in miscarried conceptus from polycystic ovary syndrome women undergoing assisted reproductive treatment.","volume":"111","author":"Li","year":"2019","journal-title":"Fertil Steril"},{"key":"R15-20260119","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/humrep\/12.7.1545","article-title":"Embryo morphology or cleavage stage: how to select the best embryos for transfer after in-vitro fertilization.","volume":"12","author":"Ziebe","year":"1997","journal-title":"Hum Reprod"},{"key":"R16-20260119","first-page":"1218","article-title":"Chinese expert consensus on morphological evaluation of human embryo and blastocyst at cleavage stage.","volume":"12","year":"2022","journal-title":"Chin J Reprod Contracept"},{"key":"R17-20260119","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00001703-199906000-00013","article-title":"Culture and transfer of human blastocysts.","volume":"11","author":"Gardner","year":"1999","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R18-20260119","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0015-0282(00)00518-5","article-title":"Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer.","volume":"73","author":"Gardner","year":"2000","journal-title":"Fertil Steril"},{"key":"R19-20260119","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3109\/09513590.2014.998187","article-title":"The dynamic changes of anti-Mullerian hormone and inhibin B during controlled ovarian hyperstimulation in decreased ovarian reserve women and the effect on clinical outcome.","volume":"31","author":"Li","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"R20-20260119","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/uog.14684","article-title":"Ovarian hyperstimulation syndrome: pathophysiology, staging, prediction and prevention.","volume":"45","author":"Nastri","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R21-20260119","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1471-0528.1997.tb11525.x","article-title":"Assisted conception following poor ovarian response to gonadotrophin stimulation.","volume":"104","author":"Keay","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"R22-20260119","first-page":"CD12103","article-title":"Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews.","volume":"1","author":"Mourad","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R23-20260119","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1210\/jc.2014-4290","article-title":"Adolescent polycystic ovary syndrome due to functional ovarian hyperandrogenism persists into adulthood.","volume":"100","author":"Rosenfield","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R24-20260119","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.fertnstert.2013.02.055","article-title":"Is the fertile window extended in women with polycystic ovary syndrome? Utilizing the society for assisted reproductive technology registry to assess the impact of reproductive aging on live-birth rate.","volume":"100","author":"Kalra","year":"2013","journal-title":"Fertil Steril"},{"key":"R25-20260119","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.fertnstert.2014.09.040","article-title":"Is polycystic ovarian morphology related to a poor oocyte quality after controlled ovarian hyperstimulation for intracytoplasmic sperm injection? Results from a prospective, comparative study.","volume":"103","author":"Sigala","year":"2015","journal-title":"Fertil Steril"},{"key":"R26-20260119","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.rbmo.2017.07.010","article-title":"Early miscarriage rate in lean polycystic ovary syndrome women after euploid embryo transfer - a matched-pair study.","volume":"35","author":"Luo","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"R27-20260119","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.rbmo.2010.11.002","article-title":"Progesterone rise on HCG day in GnRH antagonist\/rFSH stimulated cycles affects endometrial gene expression.","volume":"22","author":"Van Vaerenbergh","year":"2011","journal-title":"Reprod Biomed Online"},{"key":"R28-20260119","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.fertnstert.2021.12.025","article-title":"Optimal endometrial thickness in fresh and frozen-thaw in vitro fertilization cycles: an analysis of live birth rates from 96,000 autologous embryo transfers.","volume":"117","author":"Mahutte","year":"2022","journal-title":"Fertil Steril"},{"key":"R29-20260119","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.rbmo.2018.08.025","article-title":"Optimal endometrial thickness to maximize live births and minimize pregnancy losses: analysis of 25,767 fresh embryo transfers.","volume":"37","author":"Gallos","year":"2018","journal-title":"Reprod Biomed Online"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046509","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T19:02:02Z","timestamp":1768849322000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046509","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"2024-07-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}